First-line treatment of indolent lymphoma: axing CHOP?

Lancet. 2013 Apr 6;381(9873):1163-5. doi: 10.1016/S0140-6736(12)61965-5. Epub 2013 Feb 20.

Authors

Caron A Jacobson¹, Arnold S Freedman

Affiliation

¹ Dana-Farber Cancer Institute, Boston, MA 02215, USA.

PMID: 23433738
DOI: 10.1016/S0140-6736(12)61965-5

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Lymphoma, Mantle-Cell / drug therapy*